SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-99-011203
Filing Date
1999-12-29
Accepted
1999-12-29 00:00:00
Documents
6
Period of Report
1999-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 287428
2 RESEARCH ALLIANCE AND LICENSE AGREEMENT EX-10.38 82082
3 RESEARCH LICENSE AGREEMENT EX-10.39 146740
4 SUBSIDIARIES OF THE COMPANY EX-21 467
5 CONSENT OF KPMG LLP EX-23 997
6 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000950123-99-011203.txt   521815
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 99782528
SIC: 2835 In Vitro & In Vivo Diagnostic Substances